16-50711152-A-G
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS2
The NM_001370466.1(NOD2):c.1160A>G(p.Asn387Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000836 in 1,614,004 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. N387N) has been classified as Likely benign.
Frequency
Consequence
NM_001370466.1 missense
Scores
Clinical Significance
Conservation
Publications
- Blau syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Genomics England PanelApp, G2P, Illumina, Labcorp Genetics (formerly Invitae)
- inflammatory bowel disease 1Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001370466.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NOD2 | NM_001370466.1 | MANE Select | c.1160A>G | p.Asn387Ser | missense | Exon 4 of 12 | NP_001357395.1 | ||
| NOD2 | NM_022162.3 | c.1241A>G | p.Asn414Ser | missense | Exon 4 of 12 | NP_071445.1 | |||
| NOD2 | NM_001293557.2 | c.1160A>G | p.Asn387Ser | missense | Exon 3 of 11 | NP_001280486.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NOD2 | ENST00000647318.2 | MANE Select | c.1160A>G | p.Asn387Ser | missense | Exon 4 of 12 | ENSP00000495993.1 | ||
| NOD2 | ENST00000300589.6 | TSL:1 | c.1241A>G | p.Asn414Ser | missense | Exon 4 of 12 | ENSP00000300589.2 | ||
| NOD2 | ENST00000641284.2 | n.1160A>G | non_coding_transcript_exon | Exon 4 of 6 | ENSP00000493088.1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152172Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000716 AC: 18AN: 251288 AF XY: 0.0000883 show subpopulations
GnomAD4 exome AF: 0.0000855 AC: 125AN: 1461832Hom.: 0 Cov.: 39 AF XY: 0.0000798 AC XY: 58AN XY: 727216 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152172Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74334 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
BS1
Regional enteritis;C5201146:Blau syndrome Uncertain:1
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 414 of the NOD2 protein (p.Asn414Ser). This variant is present in population databases (rs104895429, gnomAD 0.02%). This missense change has been observed in individual(s) with Crohn disease or spondylarthropathy (PMID: 11875755, 12115249). ClinVar contains an entry for this variant (Variation ID: 97824). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt NOD2 protein function with a negative predictive value of 95%. Experimental studies have shown that this missense change affects NOD2 function (PMID: 12626759). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Yao syndrome;C5201146:Blau syndrome;CN260071:Inflammatory bowel disease 1 Uncertain:1
Blau syndrome Other:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at